The analgesic efficacy of nefopam after gynecologic laparoscopy surgery

The analgesic efficacy of nefopam in patient-controlled analgesia after gynecologic laparoscopy surgery: a randomized, double blind, non-inferiority

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004212

Enrollment

135

Registered

2019-08-19

Start date

2019-08-17

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Ten minutes before the end of the operation, the patient controlled analgesia device was connected to the patient and randomly divided into three groups according to the drug. In group N, 200 m

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ? Patients between 20 and 70 years of age who underwent laparoscopic gynecologic surgery through general anesthesia ? American Society of Anesthesiologists (ASA) physical status classification I,II ? Weight 40 ~ 75kg ? Patients who signed the agreement

Exclusion criteria

Exclusion criteria: ? patient's refusal ? Fentanyl or nefopam hypersensitive or allergic ? If the patient is undergoing analgesic treatment before surgery ? If the patient is pregnant or is pregnant ? myoma or tumor surgery ? Unregulated medical illness : Gastrointestinal ulcers, heart failure, uncontrolled diabetes, severe infection.

Design outcomes

Primary

Measure	Time frame
VAS scores up to 48 hours postoperatively	—

Secondary

Measure	Time frame
PCA usage time and usage;Assess whether PCA is disabled;Patient bolus frequency;The frequency and severity of nausea and vomiting;Patient satisfaction	—

Countries

Korea, Republic of

Contacts

Public ContactChan Noh

Chungnam National University Hospital

jyfchrh@naver.com+82-42-280-7844

Outcome results